It is well-known that prostaglandin (PG) synthetase inhibitors such as aspirin and indomethacin induce gastrointestinal ulcer both in experimental animals and humans. In addition, it has been reported that PG levels in the plasma and gastric juice of patients with ulcer are significantly lower than these levels in healthy subjects (1) . On the other hand, PGE type PGs and their analogs are effective against experimental ulcer produced in animals (2) (3) (4) (5) (6) . These results suggest that stimulants of PG synthetase may prevent ulceration in the gastrointestinal mucosa and repair an already formed ulcer. We attempted to determine whether the stimulation of PG biosynthesis in vitro by hydroxyphenyl alkanoic acids cor relates with anti-ulcerogenic activity of the acids in the rat.
PG synthetase activity was assayed according to the method of Tachizawa et al. As shown in Table 1 , PGE2 formation rate in control was 9.4% and the addition of 0.5 mM /-epinephrine bitartrate to control increased the rate to 25.3 %. When hydroxyphenyl alkanoic acids were added to control at a final concentration of 1 mM, compounds I, III-VII, X, XI and XIII having hydroxyphenyl group in their structure indicated remarkable stimulative effects on PGE2 formation. These effects were dependent on the increase in the number of hydroxy group (III, X), but not on the position of substitution of the group (VI, VII). On the contrary, compounds VIII and IX lacking the hydroxy group or having the methoxy group instead of the hydroxy showed no stimulative effects. In addition, the effects were remarkably reduced by increasing the number of methylene group of the acids (XI, XII) or substituting the pyridinyl group for the phenyl one in the structure of the acids (II). Fig. I shows the comparison between the stimulative effect of PG biosynthesis by five compounds (I, 111, IV, V, X) and that by /-epinephrine. Compound X was as potent as 1-epinephrine and compounds III and V showed approximately 0.5 times the stimulative potency of /-epinephrine. As shown in Table 1 , of nine compounds tested, I, IV, V and X exhibited potent anti-ulcerogenic effect as well as a definite stimulative effect on PG synthesis, while compounds 11 and XII showed weak effects. Compounds VIII and IX showed neither effect.
Our present results show that hydroxyphenyl alkanoic acids act as cofactors for PG synthetase like 1-epinephrine. In this connection, Collier ct al. (8) reported that emetics, purgatives and irritants which facilitate intestinal function and act as cofactors for PG synthetase, have the hydroxyphenyl group. In addition, Baumann et al. (9) reported that 3-(3,4-dihydroxyphenyl)propionic acid (X) stimulates PG synthetase in the rat renal medulla, whereas 3-(p-hydroxyphenyl)propionic acid (V) at a concentration of 1 mM has little effect.
In the present work, 1 mM 3-(p-hydroxyphenyl)propionic acid (V) showed a half stimulative effect of 0.5 mM /-epinephrine on PG synthetase in the rabbit renal medulla. The discrepancy between the results may be explained by the findings that the drug sensitivity of PG synthetase in the rabbit is remarkably higher than that in the rat (7). Moreover, our present results demonstrate that most hydroxyphenyl alkanoic acids have the ability to stimulate PG synthetase and to repair lesions in case of aspirin-induced ulcer. l-epinephrine bitartrate.
